Carvedilol has the capacity to block both the β-1 and β-2 adrenergic receptors, as well as the α-1 receptors. There is evidence to indicate that full adrenergic blockade by carvedilol improves ...
By contrast, a recent randomized, controlled trial shows less bleeding associated with the use of carvedilol compared with EBL. Portal hypertension is a life-threatening complication of cirrhosis ...
However, it has been found that additional α-adrenergic blockade with carvedilol may increase the number of patients with hemodynamic responses resulting in a reduction in hepatic venous pressure ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果